{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:05:47Z","timestamp":1790795147801,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.atherosclerosis.2016.10.042","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T20:01:02Z","timestamp":1477339262000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano\/POPC) in healthy volunteers and stable coronary artery disease patients"],"prefix":"10.1016","volume":"255","author":[{"given":"Herman J.","family":"Kempen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gomaraschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Otvos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jeyarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3680-285X","authenticated-orcid":false,"given":"David","family":"Kallend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.J.","family":"Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.10.010","article-title":"Therapeutic applications of reconstituted HDL: when structure meets function","volume":"157","author":"Darabi","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib3","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/01.CIR.90.4.1935","article-title":"Recombinant apolipoprotein A-IMilano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits","volume":"90","author":"Ameli","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.CIR.97.8.780","article-title":"Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice","volume":"97","author":"Shah","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.RES.0000018422.31717.EE","article-title":"Recombinant apolipoprotein A-IMilano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks","volume":"90","author":"Chiesa","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jacc.2007.12.010","volume":"51","author":"Parolini","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jacc.2007.09.071","article-title":"Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis","volume":"51","author":"Ibanez","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib8","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib9","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M033779","article-title":"Effect of repeated apoA-IMilano\/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys","volume":"54","author":"Kempen","year":"2013","journal-title":"J.\u00a0Lipid. Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjcvp\/pvv041","article-title":"A\u00a0single infusion of MDCO-216 (ApoA-I Milano\/POPC) profoundly increases ABCA1 mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease","volume":"2","author":"Kallend","year":"2016","journal-title":"Eur. Heart. J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib11","first-page":"A15525","article-title":"CER-001, a synthetic HDL-mimetic, safely mobilizes cholesterol in healthy dyslipidemic volunteers","volume":"124","author":"Keyserling","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/ATVBAHA.114.303720","article-title":"CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects","volume":"34","author":"Gille","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(90)90102-4","article-title":"Apolipoprotein AIMilano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme","volume":"1043","author":"Franceschini","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/ATVBAHA.115.307052","article-title":"High-density lipoprotein subfractions and cholesterol efflux capacities after infusion of MDCO-216 (apolipoprotein A-IMilano\/palmitoyl-oleoyl-phosphatidylcholine) in healthy volunteers and stable coronary artery disease patients","volume":"36","author":"Kempen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI14011","article-title":"Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems","volume":"108","author":"Krieger","year":"2001","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1074248411426144","article-title":"Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl\/6 Mice","volume":"17","author":"Chen","year":"2012","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.phrs.2016.05.001","article-title":"ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers","volume":"111","author":"Bisgaier","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehr103","article-title":"Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein","volume":"33","author":"Hoang","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib20","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1194\/jlr.M054767","article-title":"ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP\/PKA activation","volume":"56","author":"Lindahl","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.042_bib21","doi-asserted-by":"crossref","first-page":"13880","DOI":"10.1016\/S0021-9258(18)68326-7","article-title":"Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein","volume":"263","author":"Craig","year":"1988","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T03:54:33Z","timestamp":1657511673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016314459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S0021915016314459"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.042","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano\/POPC) in healthy volunteers and stable coronary artery disease patients","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}